Risk Stratification for Acute Kidney Injury: Are Biomarkers Enough?

Advances in Chronic Kidney Disease

Volumn 23, Issue 3, 2016, Pages 167-178

  McMahon, Blaithin A ^a,b   Koyner, Jay L ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Acute kidney injury; Biomarkers; Renal replacement therapy; Risk assessment

Indexed keywords

BIOLOGICAL MARKER; CREATININE; FUROSEMIDE; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG; DIURETIC AGENT; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-RELATED PROTEIN 1; TIMP2 PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; CELL CYCLE ARREST; CLINICAL PRACTICE; CONTRAST INDUCED ACUTE KIDNEY INJURY; CREATININE BLOOD LEVEL; DIAGNOSTIC KIT; DISEASE SEVERITY; FUROSEMIDE STRESS TEST; HEART SURGERY; HUMAN; KIDNEY FUNCTION TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL ANGINA INDEX; RENAL SYSTEM PARAMETERS; REVIEW; RISK FACTOR; BLOOD; EARLY DIAGNOSIS; INTENSIVE CARE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

ACUTE KIDNEY INJURY; BIOMARKERS; CRITICAL CARE; DIURETICS; EARLY DIAGNOSIS; FUROSEMIDE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84963959758     PISSN: 15485595     EISSN: 15485609     Source Type: Journal    
DOI: 10.1053/j.ackd.2016.03.001     Document Type: Review

References (104)

1. Kannel W.B., Dawber T.R., Kagan A., Revotskie N., Stokes J. Factors of risk in the development of coronary heart disease-six year follow-up experience. The Framingham Study. Ann Intern Med 1961, 55:33-50.
2. Endre Z.H., Pickering J.W. Acute kidney injury: cell cycle arrest biomarkers win race for AKI diagnosis. Nat Rev Nephrol 2014, 10(12):683-685.
3. Doi K., Katagiri D., Negishi K., et al. Mild elevation of urinary biomarkers in prerenal acute kidney injury. Kidney Int 2012, 82(10):1114-1120.
4. Nejat M., Pickering J.W., Devarajan P., et al. Some biomarkers of acute kidney injury are increased in pre-renal acute injury. Kidney Int 2012, 81(12):1254-1262.
5. Nickolas T.L., O'Rourke M.J., Yang J., et al. Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 2008, 148(11):810-819.
6. Nickolas T.L., Schmidt-Ott K.M., Canetta P., et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 2012, 59(3):246-255.
7. Hansen M.K., Gammelager H., Mikkelsen M.M., et al. Post-operative acute kidney injury and five-year risk of death, myocardial infarction, and stroke among elective cardiac surgical patients: a cohort study. Crit Care 2013, 17(6):R292.
8. Lassnigg A., Schmidlin D., Mouhieddine M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 2004, 15(6):1597-1605.
9. Chawla L.S., Amdur R.L., Shaw A.D., Faselis C., Palant C.E., Kimmel P.L. Association between AKI and long-term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol 2014, 9(3):448-456.
10. Chertow G.M., Levy E.M., Hammermeister K.E., Grover F., Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 1998, 104(4):343-348.
11. Jo S.K., Rosner M.H., Okusa M.D. Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon. Clin J Am Soc Nephrol 2007, 2(2):356-365.
12. Sileanu F.E., Murugan R., Lucko N., et al. AKI in low-risk versus high-risk patients in intensive care. Clin J Am Soc Nephrol 2015, 10(2):187-196.
13. Liano F., Gallego A., Pascual J., et al. Prognosis of acute tubular necrosis: an extended prospectively contrasted study. Nephron 1993, 63(1):21-31.
14. Chertow G.M., Soroko S.H., Paganini E.P., et al. Mortality after acute renal failure: models for prognostic stratification and risk adjustment. Kidney Int 2006, 70(6):1120-1126.
15. Bullock M.L., Umen A.J., Finkelstein M., Keane W.F. The assessment of risk factors in 462 patients with acute renal failure. Am J Kidney Dis 1985, 5(2):97-103.
16. Uchino S., Bellomo R., Morimatsu H., et al. External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med 2005, 33(9):1961-1967.
17. Mehta R.L., Pascual M.T., Gruta C.G., Zhuang S., Chertow G.M. Refining predictive models in critically ill patients with acute renal failure. J Am Soc Nephrol 2002, 13(5):1350-1357.
18. van den Akker J.P., Egal M., Groeneveld A.B. Invasive mechanical ventilation as a risk factor for acute kidney injury in the critically ill: a systematic review and meta-analysis. Crit Care 2013, 17(3):R98.
19. Bouchard J., Acharya A., Cerda J., et al. A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 2015, 10(8):1324-1331.
20. Alobaidi R., Basu R.K., Goldstein S.L., Bagshaw S.M. Sepsis-associated acute kidney injury. Semin Nephrol 2015, 35(1):2-11.
21. Martensson J., Bellomo R. Sepsis-induced acute kidney injury. Crit Care Clin 2015, 31(4):649-660.
22. Mao H., Katz N., Ariyanon W., et al. Cardiac surgery-associated acute kidney injury. Cardiorenal Med 2013, 3(3):178-199.
23. Parikh C.R., Coca S.G., Thiessen-Philbrook H., et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 2011, 22(9):1748-1757.
24. Huen S.C., Parikh C.R. Predicting acute kidney injury after cardiac surgery: a systematic review. Ann Thorac Surg 2012, 93(1):337-347.
25. Chertow G.M., Lazarus J.M., Christiansen C.L., et al. Preoperative renal risk stratification. Circulation 1997, 95(4):878-884.
26. Kelz R.R., Reinke C.E., Zubizarreta J.R., et al. Acute kidney injury, renal function, and the elderly obese surgical patient: a matched case-control study. Ann Surg 2013, 258(2):359-363.
27. Suneja M., Kumar A.B. Obesity and perioperative acute kidney injury: a focused review. J Crit Care 2014, 29(4):694.e1-694.e6.
28. Varrier M., Ostermann M. Novel risk factors for acute kidney injury. Curr Opin Nephrol Hypertens 2014, 23(6):560-569.
29. Wiedermann C.J., Wiedermann W., Joannidis M. Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 2010, 36(10):1657-1665.
30. Lapsia V., Johnson R.J., Dass B., et al. Elevated uric acid increases the risk for acute kidney injury. Am J Med 2012, 125(3):302.e9-302.e17.
31. Siew E.D., Parr S.K., Abdel-Kader K., et al. Predictors of recurrent AKI. J Am Soc Nephrol 2015, http://dx.doi.org/10.1681/ASN.2014121218. [Epub ahead of print].
32. Karvellas C.J., Durand F., Nadim M.K. Acute kidney injury in cirrhosis. Crit Care Clin 2015, 31(4):737-750.
33. Teixeira C., Garzotto F., Piccinni P., et al. Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care 2013, 17(1):R14.
34. Kiers H.D., van den Boogaard M., Schoenmakers M.C., et al. Comparison and clinical suitability of eight prediction models for cardiac surgery-related acute kidney injury. Nephrol Dial Transpl 2013, 28(2):345-351.
35. Brown J.R., Cochran R.P., Leavitt B.J., et al. Multivariable prediction of renal insufficiency developing after cardiac surgery. Circulation 2007, 116(11 Suppl):I139-I143.
36. Mehta R.H., Grab J.D., O'Brien S.M., et al. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation 2006, 114(21):2208-2216. quiz 2208.
37. Thakar C.V., Arrigain S., Worley S., Yared J.P., Paganini E.P. A clinical score to predict acute renal failure after cardiac surgery. J Am Soc Nephrol 2005, 16(1):162-168.
38. Palomba H., de Castro I., Neto A.L., Lage S., Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS Score. Kidney Int 2007, 72(5):624-631.
39. Wijeysundera D.N., Karkouti K., Dupuis J.Y., et al. Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery. JAMA 2007, 297(16):1801-1809.
40. Aronson S., Fontes M.L., Miao Y., Mangano D.T. Risk index for perioperative renal dysfunction/failure: critical dependence on pulse pressure hypertension. Circulation 2007, 115(6):733-742.
41. Rahmanian P.B., Kwiecien G., Langebartels G., Madershahian N., Wittwer T., Wahlers T. Logistic risk model predicting postoperative renal failure requiring dialysis in cardiac surgery patients. Eur J Cardiothorac Surg 2011, 40(3):701-707.
42. Fortescue E.B., Bates D.W., Chertow G.M. Predicting acute renal failure after coronary bypass surgery: cross-validation of two risk-stratification algorithms. Kidney Int 2000, 57(6):2594-2602.
43. Paganini E.P., Halstenberg W.K., Goormastic M. Risk modeling in acute renal failure requiring dialysis: the introduction of a new model. Clin Nephrol 1996, 46(3):206-211.
44. Lohr J.W., McFarlane M.J., Grantham J.J. A clinical index to predict survival in acute renal failure patients requiring dialysis. Am J Kidney Dis 1988, 11(3):254-259.
45. Demirjian S., Chertow G.M., Zhang J.H., et al. Model to predict mortality in critically ill adults with acute kidney injury. Clin J Am Soc Nephrol 2011, 6(9):2114-2120.
46. Englberger L., Suri R.M., Li Z., et al. Validation of clinical scores predicting severe acute kidney injury after cardiac surgery. Am J Kidney Dis 2010, 56(4):623-631.
47. Wong B., St Onge J., Korkola S., Prasad B. Validating a scoring tool to predict acute kidney injury (AKI) following cardiac surgery. Can J Kidney Health Dis 2015, 2:3.
48. Lins R.L., Elseviers M.M., Daelemans R., et al. Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study. Nephrol Dial Transpl 2004, 19(9):2282-2288.
49. Hausenloy D.J., Candilio L., Evans R., et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med 2015, 373(15):1408-1417.
50. Wang K., Duan C.Y., Wu J., et al. Predictive value of neutrophil gelatinase-associated lipocalin for contrast-induced acute kidney injury after cardiac catheterization: a meta-analysis. Can J Cardiol 2015, [Epub ahead of print]. 10.1016/j.cjca.2015.09.011.
51. Ling W., Zhaohui N., Ben H., et al. Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography. Nephron Clin Pract 2008, 108(3):c176-c181.
52. Kashani K., Al-Khafaji A., Ardiles T., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013, 17(1):R25.
53. Hoste E.A., McCullough P.A., Kashani K., et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transpl 2014, 29(11):2054-2061.
54. Mehran R., Aymong E.D., Nikolsky E., et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004, 44(7):1393-1399.
55. Bartholomew B.A., Harjai K.J., Dukkipati S., et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004, 93(12):1515-1519.
56. Brown J.R., DeVries J.T., Piper W.D., et al. Serious renal dysfunction after percutaneous coronary interventions can be predicted. Am Heart J 2008, 155(2):260-266.
57. Abellas-Sequeiros R.A., Raposeiras-Roubin S., Abu-Assi E., et al. Mehran contrast nephropathy risk score: is it still useful 10 years later?. J Cardiol 2016, 67(3):262-267.
58. Kolhe N.V., Stevens P.E., Crowe A.V., Lipkin G.W., Harrison D.A. Case mix, outcome and activity for patients with severe acute kidney injury during the first 24 hours after admission to an adult, general critical care unit: application of predictive models from a secondary analysis of the ICNARC Case Mix Programme database. Crit Care 2008, 12(Suppl 1):S2.
59. Ohnuma T., Uchino S., Toki N., et al. External validation for acute kidney injury severity scores: a multicenter retrospective study in 14 Japanese ICUs. Am J Nephrol 2015, 42(1):57-64.
60. Endre Z.H., Kellum J.A., Di Somma S., et al. Differential diagnosis of AKI in clinical practice by functional and damage biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013, 182:30-44.
61. Endre Z.H., Pickering J.W., Walker R.J., et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011, 79(10):1119-1130.
62. Koyner J.L., Shaw A.D., Chawla L.S., et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol 2015, 26(7):1747-1754.
63. Okusa M.D., Jaber B.L., Doran P., et al. Physiological biomarkers of acute kidney injury: a conceptual approach to improving outcomes. Contrib Nephrol 2013, 182:65-81.
64. McCullough P.A., Shaw A.D., Haase M., et al. Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol 2013, 182:13-29.
65. Endre Z.H. Using biomarkers for acute kidney injury: barriers and solutions. Nephron Clin Pract 2014, 127(1-4):180-184.
66. Koyner J.L., Parikh C.R. Clinical utility of biomarkers of AKI in cardiac surgery and critical illness. Clin J Am Soc Nephrol 2013, 8(6):1034-1042.
67. Coca S.G., Yalavarthy R., Concato J., Parikh C.R. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008, 73(9):1008-1016.
68. Bellomo R., Ronco C., Kellum J.A., Mehta R.L., Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8(4):R204-R212.
69. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11(2):R31.
70. Clinical Practice Guidelines for Acute Kidney Injury 2012 2012, Group KAw. http://www.kdigo.org/clinical_%20practice:guidelines/AKI.php.
71. Ronco C., Kellum J.A., Haase M. Subclinical AKI is still AKI. Crit Care 2012, 16(3):313.
72. Parikh C.R., Devarajan P., Zappitelli M., et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol 2011, 22(9):1737-1747.
73. Coca S.G., Jammalamadaka D., Sint K., et al. Preoperative proteinuria predicts acute kidney injury in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2012, 143(2):495-502.
74. Shlipak M.G., Coca S.G., Wang Z., et al. Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis 2011, 58(3):366-373.
75. Zappitelli M., Krawczeski C.D., Devarajan P., et al. Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int 2011, 80(6):655-662.
76. Coca S.G., Garg A.X., Thiessen-Philbrook H., et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol 2014, 25(5):1063-1071.
77. Huang T.M., Wu V.C., Young G.H., et al. Preoperative proteinuria predicts adverse renal outcomes after coronary artery bypass grafting. J Am Soc Nephrol 2011, 22(1):156-163.
78. Patel U.D., Garg A.X., Krumholz H.M., et al. Preoperative serum brain natriuretic peptide and risk of acute kidney injury after cardiac surgery. Circulation 2012, 125(11):1347-1355.
79. Koyner J.L., Garg A.X., Coca S.G., et al. Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol 2012, 23(5):905-914.
80. Moledina D.G., Parikh C.R., Garg A.X., et al. Association of perioperative plasma neutrophil gelatinase-associated lipocalin levels with 3-year mortality after cardiac surgery: a prospective observational cohort study. PLoS One 2015, 10(6):e0129619.
81. Haase M., Devarajan P., Haase-Fielitz A., et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol 2011, 57(17):1752-1761.
82. Zarbock A., Schmidt C., Van Aken H., et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA 2015, 313(21):2133-2141.
83. Meybohm P., Bein B., Brosteanu O., et al. A multicenter trial of remote ischemic preconditioning for heart surgery. N Engl J Med 2015, 373(15):1397-1407.
84. Bulent Gul C.B., Gullulu M., Oral B., et al. Urinary IL-18: a marker of contrast-induced nephropathy following percutaneous coronary intervention?. Clin Biochem 2008, 41(7-8):544-547.
85. Torregrosa I., Montoliu C., Urios A., et al. Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure. Nefrologia 2012, 32(1):44-52.
86. Chaykovska L., Heunisch F., von Einem G., et al. Urinary vitamin D binding protein and KIM-1 are potent new biomarkers of major adverse renal events in patients undergoing coronary angiography. PLoS One 2016, 11(1):e0145723.
87. Malyszko J., Bachorzewska-Gajewska H., Poniatowski B., Malyszko J.S., Dobrzycki S. Urinary and serum biomarkers after cardiac catheterization in diabetic patients with stable angina and without severe chronic kidney disease. Ren Fail 2009, 31(10):910-919.
88. Weisbord S.D., Gallagher M., Kaufman J., et al. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol 2013, 8(9):1618-1631.
89. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012, (Suppl 2):1-138. KDIGO. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group.
90. Padhy M., Kaushik S., Girish M.P., Mohapatra S., Shah S., Koner B.C. Serum neutrophil gelatinase associated lipocalin (NGAL) and cystatin C as early predictors of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Clin Chim Acta 2014, 435:48-52.
91. Kim G.S., Ko Y.G., Shin D.H., et al. Elevated serum cystatin C level is an independent predictor of contrast-induced nephropathy and adverse outcomes in patients with peripheral artery disease undergoing endovascular therapy. J Vasc Surg 2015, 61(5):1223-1230.
92. Basu R.K., Zappitelli M., Brunner L., et al. Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 2014, 85(3):659-667.
93. Koyner J.L., Coca S.G., Thiessen-Philbrook H., et al. Urine biomarkers and perioperative acute kidney injury: the impact of preoperative estimated GFR. Am J Kidney Dis 2015, 66(6):1006-1014.
94. Gibney N., Hoste E., Burdmann E.A., et al. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol 2008, 3(3):876-880.
95. Goldstein S.L., Chawla L.S. Renal angina. Clin J Am Soc Nephrol 2010, 5(5):943-949.
96. Basu R.K., Wang Y., Wong H.R., Chawla L.S., Wheeler D.S., Goldstein S.L. Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children. Clin J Am Soc Nephrol 2014, 9(4):654-662.
97. Cruz D.N., Ferrer-Nadal A., Piccinni P., et al. Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically ill adults. Clin J Am Soc Nephrol 2014, 9(4):663-672.
98. Palevsky P.M. Renal angina: right concept. . .Wrong name?. Clin J Am Soc Nephrol 2014, 9(4):633-634.
99. Chawla L.S., Davison D.L., Brasha-Mitchell E., et al. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care 2013, 17(5):R207.
100. Materson B.J. Insights into intrarenal sites and mechanisms of action of diuretic agents. Am Heart J 1983, 106(1 Pt 2):188-208.
101. Koyner J.L., Davison D.L., Brasha-Mitchell E., et al. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol 2015, 26(8):2023-2031.
102. van der Voort P.H., Boerma E.C., Koopmans M., et al. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med 2009, 37(2):533-538.
103. Testani J.M., Brisco M.A., Turner J.M., et al. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail 2014, 7(2):261-270.
104. Singh D., Shrestha K., Testani J.M., et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail 2014, 20(6):392-399.